The Recombinant Therapeutic Antibodies and Proteins Market in 2023 is US$ 184.1 billion, and is expected to reach US$ 469.68 billion by 2031 at a CAGR of 12.4%.
FutureWise Research published a report that analyzes Recombinant Therapeutic Antibodies and Proteins Market trends to predict the market's growth. The report begins with a description of the business environment and explains the...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian